be interesting to determine whether the transition to a mesenchymal fate provides an advantage to cancer cells enabling them to escape entosis, or whether entosis is deregulated in cancers. As with the initial description of a new phenomenon, which often raises more questions than it provides answers, defining the process of entosis and the genes that control it will be needed to establish its relevance in vivo.
Hematopoietic stem cells (HSCs) were once believed to avoid the ravages of age by residing in bone marrow, where they generate cells of nearly all hematopoietic lineages. Yet, HSCs are also present in blood and other tissues. Studies that measure the numbers of HSCs in blood reveal that nearly all HSCs in the bone marrow periodically enter the cell cycle (Cheshier et al., 1999; Wright et al., 2001) . In this issue, Massberg, von Andrian, and their colleagues chart new patrol routes for HSCs, deduce how their migration is controlled, and establish a raison d'être outside of the bone marrow (Massberg et al., 2007) .
There is recent support for the long-held view that HSCs reside in association with osteoblasts near trabecular bone-the tissue in the inner cavities of bones (Adams and Scadden, 2006) . This niche is thought to represent a nurturing environment, providing signals for HSC survival, relative quiescence, and self renewal (Figure 1 ). However, methods for identifying HSCs have progressively improved, and we now know that larger numbers of HSCs can be found in the more centrally located perivascular regions of bones (Kiel et al., 2005) . Although the bone marrow is still considered to be the principal site for blood cell formation, spleen and liver are also important sites for this process during fetal development. Moreover, blood cell formation in these tissues can be transiently reactivated (termed extramedullary hematopoiesis) under conditions of unusual demand for blood cells such as during a parasitic infection or during myelofibrosis.
Although mobilization of HSCs for therapeutic transplantation is being extensively studied (Winkler and Levesque, 2006) , mechanisms associated with normal egress into the circulation are poorly understood. It is likely that cell adhesion molecules, proadhesive chemokines, crowding, neutrophilderived proteases, and innervation of niches by the sympathetic nervous system all determine whether HSCs remain sessile or are induced to migrate. The blood of a mouse contains between 100 and 400 HSCs at any one time, but they reside there for only seconds, and some eventually return to the bone marrow (Wright et al., 2001 Hematopoietic stem cells (HSCs) exist in the bone marrow and circulate in the blood. In this issue, Massberg et al. (2007) report that HSCs also travel through the lymphatic system. Furthermore, migration of HSCs-which express Toll-like receptors-allows the recognition of pathogenic molecules in peripheral tissues thereby promoting the local generation of innate immune cells at the site of infection.
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Intravenously administered HSCs quickly go to the spleen and some reenter the blood for transit to a variety of tissues (Wright et al., 2001 ). In the new study, von Andrian and colleagues (Massberg et al., 2007) now show that lymph and lymph nodes represent another major migration route for HSCs (Figure 1 ). They demonstrate that HSCs reside for a time in nonhematopoietic tissues before transiting through the lymph nodes, eventually re-entering the blood circulation via the thoracic duct. Gradients of sphingosine-1-phosphate regulate egress of lymphocytes from the thymus, spleen, and lymph nodes (Pappu et al., 2007) . Massberg et al. (2007) show that recognition of sphingosine-1-phosphate by receptors on the HSCs controls their movement from tissues into the lymph. Their work also suggests that the route of HSC migration is different from that of lymphocytes. HSCs enter lymph via afferent lymphatics rather than high endothelial venules and spend little time in lymph nodes before re-entering blood via the thoracic duct. Indeed, they even recirculate via lymph in mice that lack lymph nodes.
All of these findings suggest that there is migration of HSCs, but what is the purpose? HSC and lineagespecified progenitors express functional Toll-like receptors (TLRs) (Nagai et al., 2006) . In humans as well as flies, TLRs act as sentinels in cells that express them by recognizing foreign molecules such as those expressed by pathogens. TLR ligands such as the bacterial outer membrane component lipopolysaccharide promote entry of quiescent HSCs into the cell cycle, lower the cytokine requirements for differentiation of myeloid progenitors, and direct lymphoid progenitors to take on a dendritic cell fate (Nagai et al., 2006 ; R.W., R. Pelayo, and P.K., unpublished data). Lipopolysaccharide injected intravenously quickly finds its way to HSCs in the bone marrow. This suggests that stem/progenitor cells could be stimulated at that site by circulating pathogen products, resulting in generation of more cells of the innate immune system. Massberg et al. (2007) now show that HSCs can also address the threat of infection elsewhere in the body. Coinjection of lipopolysaccharide and HSCs beneath the kidney capsule simulated an infection site; this TLR ligand encouraged retention of hematopoietic cells in peripheral tissues and stimulated their proliferation and the preferential generation of dendritic cells. These results indicate that migration enables HSCs to recognize pathogens at infection sites and rapidly produce innate immune effector cells.
These exciting observations blur the distinction between central versus peripheral hematopoiesis and raise many interesting questions. For example, does self renewal of HSCs also occur outside the bone marrow, or do HSCs expend their expansion potential while attempting to counter threats? Massberg et al. (2007) demonstrate in vivo what has been previously observed in culture (Nagai et al., 2006) , that lipopolysaccharide stimulates dendritic cell production. There are many functionally specialized types of dendritic cells, and recent findings suggest that they may have different developmental origins (Wu and Liu, 2007) . Patterns of differentiation depend on location of progenitors and exposure to growth and differentiation factors. New observations suggest that TLR ligands represent additional environmental cues for inducing dendritic cell formation, and the nature of the dendritic cells produced depends on which pathogen product is involved (Nagai et al., 2006 ; R.W., R. Pelayo, and P.K., unpublished data). Fate-mapping models need to be developed that can be used to trace dendritic cell genealogies under normal and disease circumstances.
Given the scarcity of cells involved in this study, many of the experiments and inferences pertain to myeloid progenitors or to a cell fraction comprising HSCs and progenitors together rather than to a pure HSC population. Even highly purified HSCs are heterogeneous, and subsets of HSCs appear to be intrinsically biased toward particu- Pathogen products can recruit additional HSCs to tissues, but there must be antagonistic mechanisms and ways to stimulate their self renewal. Otherwise, chronic infections would exhaust our stem cell reserve. HSCs acting as scouts in peripheral tissues would not be expected to be constrained by molecules that inhibit their proliferation in the bone marrow. Moreover, there are age-related increases in HSC numbers and skewing of myeloid-to-lymphoid differentiation (Rossi et al., 2007) . It will be interesting to determine whether migrating HSCs are particularly susceptible to aging. The seminal work of Massberg, von Andrian, and their colleagues is certain to catalyze further exploration of how migration of stem cells protects and replaces tissues.
